Regeneron Pharma (REGN) PT Lowered to $756 at Truist Securities

February 8, 2021 7:27 AM EST
Get Alerts REGN Hot Sheet
Price: $502.60 +1.61%

Rating Summary:
    28 Buy, 14 Hold, 0 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 17 | Down: 13 | New: 41
Trade Now! 
Join SI Premium – FREE
Truist Securities analyst Robyn Karnauskas lowered the price target on Regeneron Pharma (NASDAQ: REGN) to $756.00 (from $770.00) while maintaining a Buy rating.

You May Also Be Interested In





Related Categories

Analyst PT Change